Researchers at New York University (NYU) found that brain exercises from the BrainHQ app, developed by Posit Science, reduced fatigue in Multiple Sclerosis (MS) patients. This is the first study to demonstrate BrainHQ’s positive impact on MS-related fatigue, adding to existing research showing improvements in processing speed and cognitive function. The study, published in Nature: Scientific Reports, is the tenth publication on the use of BrainHQ exercises for MS patients.
This finding is particularly important for MS patients, as fatigue is a common and debilitating symptom that significantly impacts their quality of life. Current treatments for MS-related fatigue are often limited in effectiveness, highlighting the need for accessible and non-pharmacological interventions like BrainHQ. This research opens the door for a new approach to managing fatigue, potentially improving patients’ ability to participate in daily activities and enhancing their overall well-being.
The NYU study involved 117 MS patients randomized into two groups: one receiving transcranial Direct Current Stimulation (tDCS) while using BrainHQ, and the other receiving sham tDCS alongside BrainHQ training. Both groups completed thirty 20-minute BrainHQ training sessions over six weeks. Results showed a significant decrease in fatigue in both groups, with no added benefit observed from tDCS. This suggests that the BrainHQ exercises alone are driving the fatigue reduction.
This study reinforces the potential of BrainHQ exercises to address a significant unmet need for MS patients. The accessibility of the app, coupled with its demonstrated efficacy in reducing fatigue, could lead to wider adoption and integration into MS treatment plans. This could ultimately translate to improved quality of life for individuals living with MS.
Jon Napitupulu is Director of Media Relations at The Clinical Trial Vanguard. Jon, a computer data scientist, focuses on the latest clinical trial industry news and trends.
